Profile
AAPG VRTX REGN SGEN ALNY ARGX
Company Name Ascentage Pharma Group International Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.47B $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.57K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Dr. Dajun Yang M.D., Ph.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
AAPG VRTX REGN SGEN ALNY ARGX
Last Close $39.99 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $39.65 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $17.2 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High 0.86 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 132.5 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
AAPG VRTX REGN SGEN ALNY ARGX
1 Month Return 51.02 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return 116.16 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return 0 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return 0 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return 0 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return 0 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AAPG VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -4.58 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
AAPG VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 97.03 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -15.49 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -249.8 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -25.48 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 102.58 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 106.9 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -37.7 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -6.67 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 9.9 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.32 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM 4.41 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 108.26 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 37.46 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -1.47 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -1.8 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 1699.83 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -11.36 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 121.81 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -6.67 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -183.36 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -194.43 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -194.43 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
AAPG VRTX REGN SGEN ALNY ARGX
Revenue $0.98B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0.95B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 97.03% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.24B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.41B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -0.75 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
AAPG VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.87B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $2.34B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.27B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0.03B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $1.67B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $2.62B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
AAPG VRTX REGN SGEN ALNY ARGX
Net Income $-0.4B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0.01B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.11B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0.02B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ABVX Abivax SA American Depositary Shares 7.15
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to AAPG
Ticker ETF Name Weight Percentage Price
PGJ Invesco Golden Dragon China ETF 0.027 28.47
BOUT Innovator IBD Breakout Opportunities ETF 6.09 36.16
CANC Tema Oncology ETF 0.81 24.97
Unlock